Related Experiment Videos
Integrin expression on normal and neoplastic human breast epithelium
L Damjanovich1, B Fülöp, R Adány
11st Department of Surgery, University Medical School of Debrecen, Hungary.
Acta Chirurgica Hungarica
|January 1, 1997
Summary
Integrin receptor expression in breast tissue is constant in normal cells and benign tumors but significantly downregulated in malignant breast cancer. Tumor cells interacting with basement membranes show preserved integrin expression, suggesting a role in differentiation.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Integrins are crucial cell adhesion receptors mediating cell-extracellular matrix (ECM) interactions.
- Altered integrin expression is implicated in various cancers, including breast cancer.
- Understanding integrin patterns in breast tumors can provide insights into tumor behavior.
Purpose of the Study:
- To investigate the expression patterns of integrin adhesion receptors in benign and malignant breast tumors.
- To correlate integrin expression with tumor characteristics and the tumor microenvironment.
Main Methods:
- Immunohistochemical techniques were employed to examine integrin subunit expression.
- A panel of antibodies targeting alpha and beta integrin subunits was utilized.
- Expression was analyzed in normal breast epithelium, fibroadenomas, and various breast cancer types.
Main Results:
- Normal breast epithelium showed consistent integrin expression (alpha 1, 2, 3, 6, v; beta 1, 3).
- Benign fibroadenomas exhibited similar integrin expression to normal tissue.
- Malignant breast cancers displayed significant downregulation of integrin subunits.
- Tumor cells in contact with basement membrane components (laminin, collagen IV) retained integrin expression, unlike those within tumor nests.
Conclusions:
- Integrin expression is significantly altered in malignant breast tumors compared to benign counterparts.
- The presence of a basement membrane influences integrin expression in invasive tumor cells.
- Integrin expression heterogeneity in breast cancer complicates interpretation regarding clinical behavior.